» Articles » PMID: 38096401

Proteomic Changes in the Hippocampus After Repeated Explosive-Driven Blasts

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2023 Dec 14
PMID 38096401
Authors
Affiliations
Soon will be listed here.
Abstract

Repeated blast-traumatic brain injury (blast-TBI) has been hypothesized to cause persistent and unusual neurological and psychiatric symptoms in service members returning from war zones. Blast-wave primary effects have been supposed to induce damage and molecular alterations in the brain. However, the mechanisms through which the primary effect of an explosive-driven blast wave generate brain lesions and induce brain consequences are incompletely known. Prior findings from rat brains exposed to two consecutive explosive-driven blasts showed molecular changes (hyperphosphorylated-Tau, AQP4, S100β, PDGF, and DNA-polymerase-β) that varied in magnitude and direction across different brain regions. We aimed to compare, in an unbiased manner, the proteomic profile in the hippocampus of double blast vs sham rats using mass spectrometry (MS). Data showed differences in up- and down-regulation for protein abundances in the hippocampus of double blast vs sham rats. Tandem mass tag (TMT)-MS results showed 136 up-regulated and 94 down-regulated proteins between the two groups (10.25345/C52B8VP0X). These TMT-MS findings revealed changes never described before in blast studies, such as increases in MAGI3, a scaffolding protein at cell-cell junctions, which were confirmed by Western blotting analyses. Due to the absence of behavioral and obvious histopathological changes as described in our previous publications, these proteomic data further support the existence of an asymptomatic blast-induced molecular altered status (ABIMAS) associated with specific protein changes in the hippocampus of rats repeatedly expsosed to blast waves generated by explosive-driven detonations.

Citing Articles

A Systematic Review of Traumatic Brain Injury in Modern Rodent Models: Current Status and Future Prospects.

Balakin E, Yurku K, Fomina T, Butkova T, Nakhod V, Izotov A Biology (Basel). 2024; 13(10).

PMID: 39452122 PMC: 11504108. DOI: 10.3390/biology13100813.


Mapping dynamic molecular changes in hippocampal subregions after traumatic brain injury through spatial proteomics.

Maity S, Huang Y, Kilgore M, Thurmon A, Vaasjo L, Galazo M Clin Proteomics. 2024; 21(1):32.

PMID: 38735925 PMC: 11089002. DOI: 10.1186/s12014-024-09485-6.

References
1.
Wang H, Yang W, Qin Q, Yang X, Yang Y, Liu H . E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer. Mol Cancer. 2022; 21(1):151. PMC: 9306183. DOI: 10.1186/s12943-022-01622-9. View

2.
Kinch K, Fullerton J, Stewart W . One hundred years (and counting) of blast-associated traumatic brain injury. J R Army Med Corps. 2018; 165(3):180-182. PMC: 7789033. DOI: 10.1136/jramc-2017-000867. View

3.
de Jong L, Roseboom W, Kramer G . Towards low false discovery rate estimation for protein-protein interactions detected by chemical cross-linking. Biochim Biophys Acta Proteins Proteom. 2021; 1869(7):140655. DOI: 10.1016/j.bbapap.2021.140655. View

4.
Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H . Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener. 2021; 16(1):55. PMC: 8359598. DOI: 10.1186/s13024-021-00474-z. View

5.
Sajja V, Hubbard W, Hall C, Ghoddoussi F, Galloway M, VandeVord P . Enduring deficits in memory and neuronal pathology after blast-induced traumatic brain injury. Sci Rep. 2015; 5:15075. PMC: 4633584. DOI: 10.1038/srep15075. View